bt Jan Johnson for The Lund Report
Nov. 13, 2014
Eric Dishman, general manager of Intel's Health Strategy & Solutions Group, told participants at OCHIN and Oregon Medical Association’s annual symposium his “personal health tragicomedy.” It began in 1989 when he was 19, training for a marathon and a student at the University of North Carolina. Fainting spells turned into a diagnosis of kidney cancer – and a prognosis of one year to live.
His doctors argued over whether his cancer was the type that usually affects “kids or coots,” and he learned how the system wants to put all patients into a single box that determines the course of their medical journey forever.
“Egos and emotions matter,” Dishman found, with doctors thinking of him as “an article or two,” and starting him on what turned into 17 rounds of chemotherapy and a painkilling regime sending him on his way to “becoming an addict.”